O-Phospho-D-Serine
(Synonyms: D-O-Phosphoserine,D-Serine-O-Phosphate,D-SOP) 目录号 : GC11966
weak agonist of the metabotropic glutamate receptor mGluR4
Cas No.:73913-63-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
IC50: 1,260 μM for the metabotropic glutamate receptor mGluR4
O-Phospho-D-Serine is a weak agonist of the metabotropic glutamate receptor mGluR4.
mGluR4 receptors, a member of the G protein-linked family of receptors for glutamate, are negatively coupled to cAMP. Its expression is highest in granule cells of the cerebellum that send parallel fibers that synapse with Purkinje cell dendrites.
In vitro: The affinity of L-serine-O-phosphate was examined in a baby hamster kidney cells expressing subtype mGluR1 or mGluR4 of the mGluR family. Results showed that both L-serine-O-phosphate or O-Phospho-D-Serine at 3 mM did not inhibit PI-hydrolysis as stimulated by 10 μM glutamate in BHK cells expressing mGluR1. However, L-serine-O-phosphate was a potent agonist at the mGluR4 subtype, which was negatively coupled to adenylate cyclase, while O-Phospho-D-Serine was found to be weakly active [1]. In another study, to test whether phosphatidylserine was recognized by amebae, calcium-treated cells were incubated with annexin V prior to adherence to or ingestion by E. histolytica. It was found that the coreceptor could be inhibited by phospho-l-serine and to a lesser extent by O-Phospho-D-Serine but not by phospho-l-threonine, which was consistent with the coreceptor functioning in the adherence and ingestion of erythrocytes via recognition of phosphatidylserine [2].
In vivo: Up to now, there is no animal in vivo data reported.
Clinical trial: So far, no clinical study has been conducted.
References:
[1] Thomsen, C. , and Suzdak, P.D. Serine-O-phosphate has affinity for type IV, but not type I, metabotropic glutamate receptor. NeuroReport 4, 1099-1101 (1993).
[2] Boettner, D. R.,Huston, C.D.,Sullivan, J.A., et al. Entamoeba histolytica and Entamoeba dispar utilize externalized phosphatidylserine for recognition and phagocytosis of erythrocytes. Infection and Immunity 73(6), 3422-3430 (2005).
| Cas No. | 73913-63-0 | SDF | |
| 别名 | D-O-Phosphoserine,D-Serine-O-Phosphate,D-SOP | ||
| 化学名 | O-phosphono-D-serine | ||
| Canonical SMILES | O=C(O)[C@H](N)COP(O)(O)=O | ||
| 分子式 | C3H8NO6P | 分子量 | 185.1 |
| 溶解度 | ≥ 18.5mg/mL in Water with ultrasonic and warming | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 5.4025 mL | 27.0124 mL | 54.0249 mL |
| 5 mM | 1.0805 mL | 5.4025 mL | 10.805 mL |
| 10 mM | 0.5402 mL | 2.7012 mL | 5.4025 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet